OpGen Return on Investment 2014-2024 | OPGN
Current and historical return on investment (ROI) values for OpGen (OPGN) over the last 10 years.
OpGen ROI - Return on Investment Historical Data |
Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
2024-09-30 |
$-0.02B |
|
0.00% |
2024-06-30 |
$-0.03B |
|
0.00% |
2024-03-31 |
$-0.03B |
|
0.00% |
2023-12-31 |
$-0.03B |
|
-826.67% |
2023-09-30 |
$-0.02B |
|
-355.56% |
2023-06-30 |
$-0.03B |
|
-302.22% |
2023-03-31 |
$-0.03B |
$0.02B |
-178.95% |
2022-12-31 |
$-0.04B |
$0.01B |
-135.92% |
2022-09-30 |
$-0.03B |
$0.02B |
-89.21% |
2022-06-30 |
$-0.02B |
$0.03B |
-54.66% |
2022-03-31 |
$-0.02B |
$0.04B |
-48.42% |
2021-12-31 |
$-0.02B |
$0.05B |
-43.19% |
2021-09-30 |
$-0.02B |
$0.04B |
-44.66% |
2021-06-30 |
$-0.02B |
$0.06B |
-47.52% |
2021-03-31 |
$-0.03B |
$0.07B |
-56.18% |
2020-12-31 |
$-0.02B |
$0.04B |
-72.44% |
2020-09-30 |
$-0.02B |
$0.04B |
-87.91% |
2020-06-30 |
$-0.02B |
$0.04B |
-125.93% |
2020-03-31 |
$-0.01B |
$0.01B |
-247.62% |
2019-12-31 |
$-0.01B |
$0.01B |
-433.33% |
2019-09-30 |
$-0.01B |
$0.00B |
-509.09% |
2019-06-30 |
$-0.01B |
$0.00B |
-329.41% |
2019-03-31 |
$-0.01B |
$0.01B |
-254.55% |
2018-12-31 |
$-0.01B |
$0.00B |
-192.59% |
2018-09-30 |
$-0.01B |
$0.01B |
-192.00% |
2018-06-30 |
$-0.01B |
$0.01B |
-200.00% |
2018-03-31 |
$-0.01B |
$0.01B |
-346.67% |
2017-12-31 |
$-0.02B |
$0.00B |
-1000.00% |
2017-09-30 |
$-0.02B |
$0.00B |
-971.43% |
2017-06-30 |
$-0.02B |
$0.00B |
-1266.67% |
2017-03-31 |
$-0.02B |
$0.00B |
-500.00% |
2016-12-31 |
$-0.02B |
$0.00B |
-380.00% |
2016-09-30 |
$-0.02B |
$0.00B |
-292.31% |
2016-06-30 |
$-0.02B |
$0.01B |
-211.11% |
2016-03-31 |
$-0.02B |
$0.01B |
-188.89% |
2015-12-31 |
$-0.02B |
$0.01B |
-237.04% |
2015-09-30 |
$-0.01B |
$0.01B |
-320.00% |
2015-06-30 |
$-0.01B |
$0.01B |
-1800.00% |
2015-03-31 |
$-0.01B |
$0.00B |
400.00% |
2014-12-31 |
$-0.01B |
$0.00B |
666.67% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Services |
$0.043B |
$0.003B |
OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland.
|